A U.S. federal judge has raised significant doubts about the scientific evidence underpinning approximately 69,000 lawsuits alleging Johnson & Johnson's talc products caused ovarian cancer. U.S. Magistrate Judge Rukhsanah Singh stated that recent expert testimony for the plaintiffs has created "deep skepticism" about whether a reliable link can be proven between talc use and an individual's specific cancer diagnosis.
This development is a potentially major victory for Johnson & Johnson in the long-running multidistrict litigation (MDL). The judge has ordered the plaintiffs to explain why their cases should not be dismissed for failing to provide an admissible expert opinion on causation. While not an immediate dismissal, this ruling challenges the core of the plaintiffs' claims and could lead to a large portion of the cases being thrown out, dramatically altering the scope of J&J's legal and financial exposure.